Delivery Order SPE2DB22D3401-SPE2DB24FT2GQ
- Not listed
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA). The $1,803.98 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award, valued at $77,908.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award, valued at $9,589.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the pharmaceutical product XIFAXAN 550 mg Tablet 60s. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,930.58 firm fixed price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,315.91 firm fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary mechanism for the...
- This federal contract award, valued at $15,095.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XIFAXAN 550 mg tablets, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical program, valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $20,824.39, with a completion date of September 29, 2023. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $8,914.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,897.19 firm fixed-price delivery order is for the provision of 4558512753 - XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This award is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The $6,630.25 firm fixed price delivery order is for the supply of XIFAXAN 550 mg tablets, a brand name pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2GQDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $13,569.08 for the supply of XIFAXAN 550 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has also received a separate indefinite delivery contract (IDC) from DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 3/18/24 |